Overview of Acute Myeloid Leukemia:
The bone marrow is a soft, spongy tissue that has several blood vessels and exists in the center of most bones. In healthy or normal bone marrow, vital cells such as RBCs, WBCs, and platelets are produced. All these cells are essential and known for the transportation of oxygen, help combat infections and support blood clotting.
Acute myeloid leukemia (AML) is a cancer that disturbs this salient process. AML cancer affects a sort of WBC in the bone marrow known as a myeloblast. In individuals with AML cancer, the myeloblasts are not mature and normal. These essential cells do not mature or act as they should. As new myeloblasts are developed, they prevent normal cells from forming and functioning. In case of excess myeloblasts and not enough normal cells, the symptoms of Acute myeloid leukemia begin to occur.
Types of Acute Myeloid Leukemia:
- Newly diagnosed Acute Myeloid Leukemia means patients have never had this cancer before and don’t have any clinical history of myelodysplastic syndrome (MDS).
- Secondary Acute Myeloid Leukemia may develop in those with a prior hematological disorder or developed acute myeloid leukemia due to certain cytotoxic therapies.
- Relapsed Acute Myeloid Leukemia means individuals have experienced remission of disease after the initial therapy, but the manifestations of the disease, including greater myeloblast counts and reduced blood counts, have returned.
- Refractory Acute Myeloid Leukemia means your cancer has not responded to therapy.
Tibsovo Treatment for AML:
Genetic mutations are alters in the deoxyribonucleic acid of any cell. Mutations can be responsible for the development of this cancer. That is why it’s necessary to get tested for genetic mutations to help your healthcare specialist team understand which acute myeloid leukemia treatments may be apt for you.
Tibsovo (ivosidenib) by Servier Pharmaceuticals is a targeted therapy. It is commercially supplied as 250 mg tablets. The medicine acts against an IDH1 mutation, which plays a crucial role in the development of disease because it prevents myeloblasts from becoming normal WBCs.
Approximately 1 in 10 individuals with Acute Myeloid Leukemia have an IDH1 mutation. As a targeted therapy, Tibsovo Tablets 250 mg acts differently from traditional chemo. Traditional chemo kills cells that divide rapidly, including cells in normal tissues. Tibsovo is an oral medication that can help myeloblasts grow into normal blood cells by blocking mutated IDH1.
How Tibsovo Works Against Acute Myeloid Leukemia:
The medication Tibsovo is a targeted therapy. It is designed to work on cells with an IDH1 mutation. In IDH1‑mutated Acute Myeloid Leukemia, myeloblasts do not turn into completely formed, healthy WBCs. This oral medicine targets the mutation that causes myeloblasts to remain immature. By targeting the mutation named IDH1, Tibsovo (ivosidenib) helps the body return to standard blood cell counts. It acts differently from chemo in that it does not attack healthy, normal blood cells. Tibsovo may be prescribed in conjunction with the medicine azacitidine.
How and Where to Buy Tibsovo:
Understanding the ideal Tibsovo price in India would assist in evaluating the overall cost of treatment. To get the accurate and latest pricing information, it is crucial to know the treatment recommendations in the context of the dosage and quantity of medicines. Legally importing products like Tibsovo tablets is recommended in order to make sure genuineness of the medicine.
It may seem tough for patients if they want to source or buy Tibsovo from India, which is not registered in India. If all the needed documents are available, then it is very easy to secure an import permit from CDSCO. To buy Tibsovo legally, Patients, Hospitals, and Health Specialists can confidently engage with a licensed service provider INDIAN PHARMA NETWORK (IPN).
Kindly make an inquiry either via Call/WhatsApp: +919310090915 or TOLL-FREE: 1800-889-1064. IPN is a WHO GDP, ISO 9001 2015 certified Pharmaceutical Wholesaler, Exporter, Importer, and Tibsovo supplier in India. We can help facilitate the supply of Tibsovo 250 mg tablets in India and other countries across the world.
